The manufacturing sector has reached an inflection point in its digitization journey. The availability of high-powered mobile devices (smartphones, tablets and the like), the industrial internet of things (IIoT), massive data creation, artificial intelligence, cloud-based technologies and the drive for competitive advantage have sparked a transformation not seen since the advent of the assembly line.

When the clock struck midnight on January 1st, it didn’t just usher in the fresh start of a new year. It also marked the first day of a landmark nationwide mandate for curbing the opioid epidemic: Beginning in 2023, healthcare organizations and providers must electronically prescribe all Schedule II, III, IV, and V controlled substances covered by Medicare Part D.

Although often overshadowed by major news and events, drug diversion – the rerouting of medications intended for patients by healthcare staff and is actually theft – has been a persistent problem in all healthcare settings. Pharmacies, doctors’ offices, hospitals, and care homes are all places drug diversion can occur if prescribing is not carefully monitored and managed.

Read the full article at www.HeathcareITToday.com